The Chemours Company (NYSE:CC) Shares Sold by American International Group Inc.

American International Group Inc. cut its stake in The Chemours Company (NYSE:CCFree Report) by 3.9% in the fourth quarter, HoldingsChannel reports. The fund owned 200,507 shares of the specialty chemicals company’s stock after selling 8,122 shares during the period. American International Group Inc.’s holdings in Chemours were worth $6,324,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently bought and sold shares of the stock. Boulder Hill Capital Management LP acquired a new position in Chemours in the fourth quarter valued at approximately $410,000. Scotia Capital Inc. increased its position in shares of Chemours by 15.2% in the fourth quarter. Scotia Capital Inc. now owns 13,704 shares of the specialty chemicals company’s stock valued at $432,000 after buying an additional 1,808 shares in the last quarter. Jade Capital Advisors LLC increased its position in shares of Chemours by 400.0% in the fourth quarter. Jade Capital Advisors LLC now owns 50,000 shares of the specialty chemicals company’s stock valued at $1,577,000 after buying an additional 40,000 shares in the last quarter. TFO Wealth Partners LLC increased its position in shares of Chemours by 204,700.0% in the fourth quarter. TFO Wealth Partners LLC now owns 4,096 shares of the specialty chemicals company’s stock valued at $129,000 after buying an additional 4,094 shares in the last quarter. Finally, Treasurer of the State of North Carolina increased its position in shares of Chemours by 1.0% in the fourth quarter. Treasurer of the State of North Carolina now owns 65,924 shares of the specialty chemicals company’s stock valued at $2,079,000 after buying an additional 640 shares in the last quarter. 76.26% of the stock is owned by institutional investors and hedge funds.

Chemours Stock Down 1.0 %

Shares of CC opened at $23.94 on Tuesday. The company has a debt-to-equity ratio of 5.26, a quick ratio of 0.99 and a current ratio of 1.61. The stock has a 50 day moving average price of $26.91 and a 200 day moving average price of $28.15. The stock has a market capitalization of $3.56 billion, a price-to-earnings ratio of -11.03 and a beta of 1.83. The Chemours Company has a one year low of $15.10 and a one year high of $39.05.

Chemours (NYSE:CCGet Free Report) last issued its earnings results on Tuesday, April 30th. The specialty chemicals company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.07. The company had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.35 billion. Chemours had a positive return on equity of 46.67% and a negative net margin of 5.51%. The firm’s quarterly revenue was down 12.1% on a year-over-year basis. During the same period in the prior year, the business earned $0.98 EPS. Equities research analysts forecast that The Chemours Company will post 1.88 earnings per share for the current fiscal year.

Chemours Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, June 14th. Shareholders of record on Wednesday, May 15th will be issued a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 4.18%. The ex-dividend date is Tuesday, May 14th. Chemours’s payout ratio is currently -46.08%.

Analysts Set New Price Targets

A number of analysts have recently commented on CC shares. UBS Group boosted their price objective on Chemours from $21.00 to $28.00 and gave the company a “neutral” rating in a research report on Tuesday, April 2nd. Mizuho assumed coverage on Chemours in a research report on Friday. They issued a “neutral” rating and a $25.00 price objective for the company. Barclays dropped their price target on Chemours from $32.00 to $30.00 and set an “equal weight” rating for the company in a research report on Tuesday, April 2nd. Finally, BMO Capital Markets upgraded Chemours from an “underperform” rating to an “outperform” rating and boosted their price target for the stock from $19.00 to $34.00 in a research report on Tuesday, April 9th. Eight research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $30.89.

Read Our Latest Analysis on CC

Chemours Profile

(Free Report)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

Read More

Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Chemours Company (NYSE:CCFree Report).

Institutional Ownership by Quarter for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.